Anemia in chronic kidney disease patients: treatment recommendations and emerging therapies.

@article{Vecchio2014AnemiaIC,
  title={Anemia in chronic kidney disease patients: treatment recommendations and emerging therapies.},
  author={Lucia R Del Vecchio and Francesco Locatelli},
  journal={Expert review of hematology},
  year={2014},
  volume={7 4},
  pages={495-506}
}
Erythropoiesis-stimulating agents (ESA) and iron have been available since decades to treat anemia of chronic kidney disease (CKD). However, many grey areas surround the field. The optimal hemoglobin (Hb) target to aimed at with ESA, the general safety of ESA and boundaries to not be exceeded with iron supplementation are still to be clearly defined. New strategies to stimulate erythropoiesis and new iron molecules have been developed; the most promising approach is the manipulation of the… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 2 times over the past 90 days. VIEW TWEETS